- Home
- QBTS vs QGEN Comparison
QBTS vs QGEN Comparison
Compare QBTS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- QGEN
- Stock Information
- Founded
- QBTS 1999
- QGEN 1986
- Country
- QBTS United States
- QGEN Netherlands
- Employees
- QBTS N/A
- QGEN N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QBTS Technology
- QGEN Health Care
- Exchange
- QBTS Nasdaq
- QGEN Nasdaq
- Market Cap
- QBTS 9.0B
- QGEN 10.1B
- IPO Year
- QBTS N/A
- QGEN 1996
- Fundamental
- Price
- QBTS $43.03
- QGEN N/A
- Analyst Decision
- QBTS Strong Buy
- QGEN Buy
- Analyst Count
- QBTS 10
- QGEN 8
- Target Price
- QBTS $20.50
- QGEN $50.68
- AVG Volume (30 Days)
- QBTS 74.5M
- QGEN 1.1M
- Earning Date
- QBTS 11-13-2025
- QGEN 11-04-2025
- Dividend Yield
- QBTS N/A
- QGEN 3.18%
- EPS Growth
- QBTS N/A
- QGEN 405.09
- EPS
- QBTS N/A
- QGEN 1.69
- Revenue
- QBTS $22,275,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- QBTS $183.72
- QGEN $7.37
- Revenue Next Year
- QBTS $55.91
- QGEN $5.74
- P/E Ratio
- QBTS N/A
- QGEN $27.89
- Revenue Growth
- QBTS 120.20
- QGEN 5.15
- 52 Week Low
- QBTS $0.98
- QGEN $37.63
- 52 Week High
- QBTS $45.30
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- QBTS 80.24
- QGEN 57.88
- Support Level
- QBTS $32.49
- QGEN $46.45
- Resistance Level
- QBTS $39.55
- QGEN $47.93
- Average True Range (ATR)
- QBTS 4.14
- QGEN 0.76
- MACD
- QBTS 1.07
- QGEN 0.30
- Stochastic Oscillator
- QBTS 89.50
- QGEN 89.38
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).